专利号:US-5283343-A 优先权日:1987-08-17 标 题 :2-aryl substituted N-acetyltryptamines and process of preparing such 发明人:DUBOCOVICH MARGARITA L; RAJADHYAKSHA VITHAL J; PECK JAMES V; HELMY ATEF A 权利人:WHITBY RESEARCH INC 摘要:This invention relates to novel melatonin derivatives, such as 2-aryl substituted N-acetyltryptamines, having pharmacological activity, e.g., melatonin antagonist activity, and methods for the synthesis thereof.
专利号:BR-112016017679-B1 优先权日:2014-02-21 标题 :5-BENZYLISOQUINOLINE DERIVATIVE COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, PROCESS FOR THE SYNTHESIS OF SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
专利号:CN-114478408-A 优先权日:2022-01-24 标 题:Method for continuous synthesis of homopiperazine
专利号:US-2014315720-A1 优先权日:2012-10-24 标 题 :Polysaccharide ester microspheres and methods and articles relating thereto 发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY 权利人:CELANESE ACETATE LLC 摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
专利号:US-12264146-B2 优先权日:2018-10-30 标 题 :Rho kinase inhibitor, method for preparing same and uses thereof 发明人:ZHANG BAOXIAN; ZHANG HONGWU; HU JIE; KANG ZHIYUN; XUE CHUNMEI; LI WENHUI; SONG YANWEI; WU ZHENZHEN; CHEN ANPING; WANG FANG; REN HENGCHUN; LI JUN 权利人:BEIJING INCREASE INNOVATIVE DRUG CO LTD 摘要:Provided are a Rho kinase inhibitor, a method for preparing same and the uses thereof. The Rho kinase inhibitor designates a compound of Formula I, a stereoisomer thereof or pharmaceutically acceptable salt thereof. The Rho kinase inhibitor promotes endothelial cells and endothelin expression, prostenin expression, and vascular factors NO synthesis and secretion, has a promoting effect on proprostin expression independently of the doses used, shows lower toxicity, while being safer.
专利号:CN-102603715-A 优先权日:2012-03-31 标 题 :A kind of synthesis and preparation method of fasudil hydrochloride
1: Shi J, Wei L. Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil. J Cardiovasc Pharmacol. 2013 Oct;62(4):341-54. doi: 10.1097/FJC.0b013e3182a3718f. Review. 2: Chen M, Liu A, Ouyang Y, Huang Y, Chao X, Pi R. Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders? Expert Opin Investig Drugs. 2013 Apr;22(4):537-50. doi: 10.1517/13543784.2013.778242. Epub 2013 Mar 5. Review. Review. Review. Japanese. Review. Review. Review. Japanese.
合成参考文献
摘要:Iyakuhin Kenkyu. Study of Medical Supplies., 26(740), 1995 参考文献:10.1007/s12028-014-9973-z 摘要:Tagami T, Kuwamoto K, Watanabe A, Unemoto K, Yokobori S, Matsumoto G, Igarashi Y, Yokota H; SAH PiCCO Study Group. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2014 Dec;21(3):462–9. doi: 10.1007/s12028-014-9973-z.